Pub Date : 2026-02-20DOI: 10.2340/17453674.2026.45443
Pernille Melbye, That Minh Pham, Niels-Peter Brøchner Nygaard, Carsten Hanshelge Kock-Jensen, Per Hviid Gundtoft, Bjarke Viberg
Background and purpose: One of the most severe complications of distal radius fractures (DRF) is the development of complex regional pain syndrome (CRPS). The incidence proportion (IP) of CRPS following DRF varies widely in the literature. Our aim is to report the incidence proportion of CRPS in DRF patients, subgrouping on age, sex, and treatment choice, and secondarily to assess development over time.
Methods: Data was extracted from the Danish National Patient Register on patients > 18 years diagnosed with a DRF (S525) in the period 1998-2017.
Results: There were 247,128 DRF in 203,533 patients with a mean age of 61 years. 75% were females. Within 1 year, 493 DRF patients developed CRPS corresponding to a 1-year IP of 0.20% and with an incidence density of 0.57/100,000/year. Median time from DRF to diagnosis was 89 days (SD 73). The IP ranged from 0.01% to 0.39% between age groups with the 30-65-year-olds having the highest incidence proportion. The surgically treated group had an IP of 0.31% and the non-surgical group had an IP of 0.17%. CRPS was slightly more common in women than men (0.21% vs 0.16%). We found a decrease in IP after 2010 from 0.24% to 0.14%.
Conclusion: There was a low IP of CRPS diagnosis after DRF treatment with an observed higher IP in the 30-65-year-olds and in surgically treated patients. We consider this to be a minimum IP due to possible undiagnosed cases, but the overall results may be closer to the clinical reality than previous studies.
{"title":"Incidence proportion of complex regional pain syndrome (CRPS) after distal radius fracture: a population-based register study.","authors":"Pernille Melbye, That Minh Pham, Niels-Peter Brøchner Nygaard, Carsten Hanshelge Kock-Jensen, Per Hviid Gundtoft, Bjarke Viberg","doi":"10.2340/17453674.2026.45443","DOIUrl":"10.2340/17453674.2026.45443","url":null,"abstract":"<p><strong>Background and purpose: </strong> One of the most severe complications of distal radius fractures (DRF) is the development of complex regional pain syndrome (CRPS). The incidence proportion (IP) of CRPS following DRF varies widely in the literature. Our aim is to report the incidence proportion of CRPS in DRF patients, subgrouping on age, sex, and treatment choice, and secondarily to assess development over time.</p><p><strong>Methods: </strong> Data was extracted from the Danish National Patient Register on patients > 18 years diagnosed with a DRF (S525) in the period 1998-2017.</p><p><strong>Results: </strong> There were 247,128 DRF in 203,533 patients with a mean age of 61 years. 75% were females. Within 1 year, 493 DRF patients developed CRPS corresponding to a 1-year IP of 0.20% and with an incidence density of 0.57/100,000/year. Median time from DRF to diagnosis was 89 days (SD 73). The IP ranged from 0.01% to 0.39% between age groups with the 30-65-year-olds having the highest incidence proportion. The surgically treated group had an IP of 0.31% and the non-surgical group had an IP of 0.17%. CRPS was slightly more common in women than men (0.21% vs 0.16%). We found a decrease in IP after 2010 from 0.24% to 0.14%.</p><p><strong>Conclusion: </strong> There was a low IP of CRPS diagnosis after DRF treatment with an observed higher IP in the 30-65-year-olds and in surgically treated patients. We consider this to be a minimum IP due to possible undiagnosed cases, but the overall results may be closer to the clinical reality than previous studies.</p>","PeriodicalId":6916,"journal":{"name":"Acta Orthopaedica","volume":"97 ","pages":"105-109"},"PeriodicalIF":2.4,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12922478/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146257017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-16DOI: 10.2340/17453674.2026.45365
Frederik O Lambers Heerspink, Egbert J D Veen, Oscar Dorrestijn, Cornelis P J Visser, Maarten J C Leijs, Dennis Van Poppel, Peter A Stroomberg, Ramon P G Ottenheijm, Jan W Kallewaard, Tjerk J W De Ruiter, Henk A Martens, Femke M Janssen, Tessa Geltink, Matthijs S Ruiter, Jos J A M Van Raaij
Background and purpose: In 2013, the first clinical practice guideline for subacromial pain syndrome (SAPS) was developed in the Netherlands to support healthcare professionals. SAPS refers to non-traumatic, non-rheumatologic shoulder complaints that are particularly painful during arm elevation. It includes conditions such as supraspinatus tendinosis, calcific tendinitis, and degenerative supraspinatus tears. Over 50,000 patients annually consult orthopedic surgeons for these issues. In response to new evidence and clinical needs, an updated guideline was developed. Part 1 addresses prevention, diagnosis, imaging, and non-surgical treatment. Using a multidisciplinary, evidence-based approach, the guideline aims to answer key clinical questions around SAPS.
Methods: Initiated by the Dutch Orthopedic Society, the guideline committee identified knowledge gaps through group sessions. Each module was based on a PICO-formatted key question and reviewed by professionals from different fields. The AGREE and GRADE methods were applied to ensure a systematic evaluation of evidence, leading to conclusions and recommendations.
Results: (i) Inform patients about the potential positive effects of a healthy lifestyle and encourage gradual exercise within sport and work. (ii) Perform a cluster of physical diagnostic tests to diagnose SAPS. (iii) Perform ultrasonography in patients with clinical suspicion of (partial thickness) rupture of the supraspinatus tendon. Consider MRI if ultrasound is not available or inconclusive. (iv) Consider barbotage for symptomatic calcific tendinosis, preferably with corticosteroid injection in the bursa, if a previous corticosteroid injection was ineffective. (v) Consider a subacromial corticosteroid injection (with a local anesthetic) to enable exercise therapy in patients with severe complaints that impair their ability to participate in exercise therapy. (vi) Consider suprascapular nerve block for patients with therapy-resistant SAPS when other non-surgical treatment is ineffective.
Conclusion: The updated guideline provides multidisciplinary recommendations for physical examination, imaging, and conservative management of SAPS.
{"title":"Update of guideline for diagnosis and treatment of subacromial pain syndrome: a multidisciplinary review by the Dutch Orthopedic Association Part 1: preventive measures, diagnostics, and non-surgical treatment of subacromial pain syndrome.","authors":"Frederik O Lambers Heerspink, Egbert J D Veen, Oscar Dorrestijn, Cornelis P J Visser, Maarten J C Leijs, Dennis Van Poppel, Peter A Stroomberg, Ramon P G Ottenheijm, Jan W Kallewaard, Tjerk J W De Ruiter, Henk A Martens, Femke M Janssen, Tessa Geltink, Matthijs S Ruiter, Jos J A M Van Raaij","doi":"10.2340/17453674.2026.45365","DOIUrl":"10.2340/17453674.2026.45365","url":null,"abstract":"<p><strong>Background and purpose: </strong> In 2013, the first clinical practice guideline for subacromial pain syndrome (SAPS) was developed in the Netherlands to support healthcare professionals. SAPS refers to non-traumatic, non-rheumatologic shoulder complaints that are particularly painful during arm elevation. It includes conditions such as supraspinatus tendinosis, calcific tendinitis, and degenerative supraspinatus tears. Over 50,000 patients annually consult orthopedic surgeons for these issues. In response to new evidence and clinical needs, an updated guideline was developed. Part 1 addresses prevention, diagnosis, imaging, and non-surgical treatment. Using a multidisciplinary, evidence-based approach, the guideline aims to answer key clinical questions around SAPS.</p><p><strong>Methods: </strong> Initiated by the Dutch Orthopedic Society, the guideline committee identified knowledge gaps through group sessions. Each module was based on a PICO-formatted key question and reviewed by professionals from different fields. The AGREE and GRADE methods were applied to ensure a systematic evaluation of evidence, leading to conclusions and recommendations.</p><p><strong>Results: </strong> (i) Inform patients about the potential positive effects of a healthy lifestyle and encourage gradual exercise within sport and work. (ii) Perform a cluster of physical diagnostic tests to diagnose SAPS. (iii) Perform ultrasonography in patients with clinical suspicion of (partial thickness) rupture of the supraspinatus tendon. Consider MRI if ultrasound is not available or inconclusive. (iv) Consider barbotage for symptomatic calcific tendinosis, preferably with corticosteroid injection in the bursa, if a previous corticosteroid injection was ineffective. (v) Consider a subacromial corticosteroid injection (with a local anesthetic) to enable exercise therapy in patients with severe complaints that impair their ability to participate in exercise therapy. (vi) Consider suprascapular nerve block for patients with therapy-resistant SAPS when other non-surgical treatment is ineffective.</p><p><strong>Conclusion: </strong> The updated guideline provides multidisciplinary recommendations for physical examination, imaging, and conservative management of SAPS.</p>","PeriodicalId":6916,"journal":{"name":"Acta Orthopaedica","volume":"97 ","pages":"91-98"},"PeriodicalIF":2.4,"publicationDate":"2026-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12908218/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146256668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-16DOI: 10.2340/17453674.2026.45293
Thies J N Van der Lelij, Bart G Pijls, Bart L Kaptein, Liza N Van Steenbergen, Rob G H H Nelissen, Perla J Marang-van de Mheen
Background and purpose: Radiostereometric analysis (RSA) of total knee arthroplasty (TKA) is used as an early safeguard during the phased evidence-based introduction of new implants. The goal of our study was to compare the long-term revision risk between RSA-tested implants and non-RSA-tested implants in the Netherlands using patient-level data.
Methods: All primary TKAs between 2007 and 2016 from the Dutch Arthroplasty Register were included, and procedures with an RSA-tested implant were identified. Both all-cause major revision risk and revision risk because of loosening were calculated at 5 and 10 years postoperatively using Kaplan-Meier analyses. Sensitivity analyses were performed with stricter definitions of implant characteristics to classify procedures as RSA-tested, to avoid camouflage of different subdesigns within the same brand implant portfolio.
Results: 83,638 RSA-tested and 104,105 non-RSA-tested TKAs were included. Cumulative all-cause major revision percentages for the RSA-tested group at 5 and 10 years were 2.2% (95% confidence interval [CI] 2.1-2.3) and 3.6% (CI 3.4-3.7), respectively, compared with 2.5% (CI 2.4-2.6) and 3.3% (CI 3.2-3.4) for the non-RSA-tested group. RSA-tested TKAs showed higher 10-year revision risks because of loosening than non-RSA-tested procedures (1.8%, CI 1.7-1.9 vs 1.4%, CI 1.3-1.4, respectively). Comparable results were found after stratification by various patient characteristics and with stricter classification approaches.
Conclusion: Regarding all-cause revision risk, RSA-tested TKAs had a slightly lower risk at 5 years. However, at 10 years the RSA-tested TKAs had a higher all-cause revision risk and higher revision risk because of loosening compared with the non-RSA-tested TKAs.
背景和目的:全膝关节置换术(TKA)的放射立体分析(RSA)被用作阶段性循证引入新植入物的早期保障措施。我们研究的目的是比较在荷兰使用患者水平数据进行rsa检测的植入物和非rsa检测的植入物的长期翻修风险。方法:纳入2007年至2016年荷兰关节置换术登记册中所有原发性tka,并确定采用rsa测试的植入物的手术。使用Kaplan-Meier分析计算术后5年和10年的全因主要翻修风险和因松动导致的翻修风险。敏感性分析采用更严格的植入物特征定义,将程序分类为rsa测试,以避免在同一品牌植入物组合中伪装不同的子设计。结果:共纳入83,638例rsa检测tka和104,105例非rsa检测tka。rsa检测组在5年和10年的累积全因主要修订百分比分别为2.2%(95%可信区间[CI] 2.1-2.3)和3.6% (CI 3.4-3.7),而非rsa检测组为2.5% (CI 2.4-2.6)和3.3% (CI 3.2-3.4)。rsa测试的tka显示出更高的10年修订风险,因为松动比非rsa测试的程序(1.8%,CI 1.7-1.9 vs 1.4%, CI 1.3-1.4)。根据不同的患者特征和更严格的分类方法进行分层后,发现了可比较的结果。结论:关于全因修正风险,rsa检测的tka在5年时的风险略低。然而,在10年时,与未进行rsa检测的tka相比,经rsa检测的tka具有更高的全因翻修风险和因松动而导致的翻修风险。
{"title":"The long-term revision risk of RSA-tested and non-RSA-tested TKA implants in The Netherlands: a Dutch arthroplasty register study.","authors":"Thies J N Van der Lelij, Bart G Pijls, Bart L Kaptein, Liza N Van Steenbergen, Rob G H H Nelissen, Perla J Marang-van de Mheen","doi":"10.2340/17453674.2026.45293","DOIUrl":"10.2340/17453674.2026.45293","url":null,"abstract":"<p><strong>Background and purpose: </strong> Radiostereometric analysis (RSA) of total knee arthroplasty (TKA) is used as an early safeguard during the phased evidence-based introduction of new implants. The goal of our study was to compare the long-term revision risk between RSA-tested implants and non-RSA-tested implants in the Netherlands using patient-level data.</p><p><strong>Methods: </strong> All primary TKAs between 2007 and 2016 from the Dutch Arthroplasty Register were included, and procedures with an RSA-tested implant were identified. Both all-cause major revision risk and revision risk because of loosening were calculated at 5 and 10 years postoperatively using Kaplan-Meier analyses. Sensitivity analyses were performed with stricter definitions of implant characteristics to classify procedures as RSA-tested, to avoid camouflage of different subdesigns within the same brand implant portfolio.</p><p><strong>Results: </strong> 83,638 RSA-tested and 104,105 non-RSA-tested TKAs were included. Cumulative all-cause major revision percentages for the RSA-tested group at 5 and 10 years were 2.2% (95% confidence interval [CI] 2.1-2.3) and 3.6% (CI 3.4-3.7), respectively, compared with 2.5% (CI 2.4-2.6) and 3.3% (CI 3.2-3.4) for the non-RSA-tested group. RSA-tested TKAs showed higher 10-year revision risks because of loosening than non-RSA-tested procedures (1.8%, CI 1.7-1.9 vs 1.4%, CI 1.3-1.4, respectively). Comparable results were found after stratification by various patient characteristics and with stricter classification approaches.</p><p><strong>Conclusion: </strong> Regarding all-cause revision risk, RSA-tested TKAs had a slightly lower risk at 5 years. However, at 10 years the RSA-tested TKAs had a higher all-cause revision risk and higher revision risk because of loosening compared with the non-RSA-tested TKAs.</p>","PeriodicalId":6916,"journal":{"name":"Acta Orthopaedica","volume":"97 ","pages":"76-82"},"PeriodicalIF":2.4,"publicationDate":"2026-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12908125/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146256629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-16DOI: 10.2340/17453674.2026.45410
Frederik O Lambers Heerspink, Egbert J D Veen, Oscar Dorrestijn, Cornelis P J Visser, Maarten J C Leijs, Dennis Van Poppel, Peter A Stroomberg, Ramon P G Ottenheijm, Jan W Kallewaard, Tjerk J W De Ruiter, Henk A Martens, Femke M Janssen, Tessa Geltink, Matthijs S Ruiter, Jos J A M Van Raaij
Background and purpose: In 2013, the first clinical practice guideline for subacromial pain syndrome (SAPS) was developed in the Netherlands to support healthcare professionals. SAPS refers to non-traumatic, non-rheumatologic shoulder complaints that are particularly painful during arm elevation. It includes conditions such as supraspinatus tendinosis, calcific tendinitis, and degenerative supraspinatus tears. Over 50,000 patients annually consult orthopedic surgeons for these issues. In response to new evidence and clinical needs, an updated guideline was developed. Part 2 focuses on supraspinatus tears, biceps tendon pathology, and calcific tendinosis. Using a multidisciplinary, evidence-based approach, the guideline aims to answer key clinical questions around SAPS.
Methods: Initiated by the Dutch Orthopedic Society, the guideline committee identified knowledge gaps through group sessions. Each module was based on a PICO-formatted key question and reviewed by professionals from different fields. The AGREE and GRADE methods were applied to ensure a systematic evaluation of evidence, leading to conclusions and recommendations.
Results: (i) Start with exercise-based therapy (with corticosteroid injection) for isolated, symptomatic, non-traumatic supraspinatus tears. Consider cuff repair if no improvement after 3-6 months. (ii) Avoid biceps tenotomy/tenodesis on a healthy tendon unless at risk during cuff repair. (iii) Evaluate patient- and tear-specific factors; use MRI for detailed assessment. (iv) Consider barbotage for calcific tendinosis; repeat once if needed. Reserve surgery for persistent large calcifications. (v) Postoperative immobilization should not exceed 3 weeks.
Conclusion: The updated guideline provides multidisciplinary recommendations for surgical management.
{"title":"Update of guideline for diagnosis and treatment of subacromial pain syndrome: a multidisciplinary review by the Dutch Orthopedic Association Part 2: Operative considerations and treatment of various conditions related to subacromial pain syndrome.","authors":"Frederik O Lambers Heerspink, Egbert J D Veen, Oscar Dorrestijn, Cornelis P J Visser, Maarten J C Leijs, Dennis Van Poppel, Peter A Stroomberg, Ramon P G Ottenheijm, Jan W Kallewaard, Tjerk J W De Ruiter, Henk A Martens, Femke M Janssen, Tessa Geltink, Matthijs S Ruiter, Jos J A M Van Raaij","doi":"10.2340/17453674.2026.45410","DOIUrl":"10.2340/17453674.2026.45410","url":null,"abstract":"<p><strong>Background and purpose: </strong> In 2013, the first clinical practice guideline for subacromial pain syndrome (SAPS) was developed in the Netherlands to support healthcare professionals. SAPS refers to non-traumatic, non-rheumatologic shoulder complaints that are particularly painful during arm elevation. It includes conditions such as supraspinatus tendinosis, calcific tendinitis, and degenerative supraspinatus tears. Over 50,000 patients annually consult orthopedic surgeons for these issues. In response to new evidence and clinical needs, an updated guideline was developed. Part 2 focuses on supraspinatus tears, biceps tendon pathology, and calcific tendinosis. Using a multidisciplinary, evidence-based approach, the guideline aims to answer key clinical questions around SAPS.</p><p><strong>Methods: </strong> Initiated by the Dutch Orthopedic Society, the guideline committee identified knowledge gaps through group sessions. Each module was based on a PICO-formatted key question and reviewed by professionals from different fields. The AGREE and GRADE methods were applied to ensure a systematic evaluation of evidence, leading to conclusions and recommendations.</p><p><strong>Results: </strong> (i) Start with exercise-based therapy (with corticosteroid injection) for isolated, symptomatic, non-traumatic supraspinatus tears. Consider cuff repair if no improvement after 3-6 months. (ii) Avoid biceps tenotomy/tenodesis on a healthy tendon unless at risk during cuff repair. (iii) Evaluate patient- and tear-specific factors; use MRI for detailed assessment. (iv) Consider barbotage for calcific tendinosis; repeat once if needed. Reserve surgery for persistent large calcifications. (v) Postoperative immobilization should not exceed 3 weeks.</p><p><strong>Conclusion: </strong> The updated guideline provides multidisciplinary recommendations for surgical management.</p>","PeriodicalId":6916,"journal":{"name":"Acta Orthopaedica","volume":"97 ","pages":"99-104"},"PeriodicalIF":2.4,"publicationDate":"2026-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12908219/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146256665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-16DOI: 10.2340/17453674.2026.45364
Mathijs Suijkerbuijk, Daan Cranenbroek, Sara I Van Ameijden, Pim W Van Egmond, Margot C W Joosen, Mariska A C De Jongh, Ruth E Geuze
Background and purpose: Traumatic fractures of the thoracolumbar spine happen in the younger, working-age population and often compromise return to work (RTW), a key factor in functional recovery and overall quality of life. Our review summarizes the current evidence on RTW following traumatic thoracolumbar fractures without spinal cord injury.
Methods: A comprehensive literature search was conducted in Embase, Medline (OvidSP), Web of Science, CINAHL and Cochrane through July 2025. Studies were included if they met the following criteria: (i) traumatic thoracolumbar spine fracture without spinal cord injury, (ii) RTW reported as an outcome measure, (iii) prospective or retrospective cohort study or case-control design, and (iv) availability of a full-text article. Risk of bias was assessed for each included study.
Results: 31 studies met the inclusion criteria. Follow-up ranged from 3 to 226 months. Only 8 out of 31 studies were rated as low risk of bias. Reported RTW rates varied widely: 25% to 100% after surgical treatment (n = 19 studies) and 38% to 100% after non-surgical treatment (n = 19 studies). Pooled estimates showed that the mean RTW is between 76% and 84% in patients with a thoracolumbar spine fracture, irrespective of treatment modality.
Conclusion: Estimated RTW rates range between 76% and 84%.
{"title":"Return to work following traumatic fractures of the thoracolumbar spine without spinal cord injury: a scoping review.","authors":"Mathijs Suijkerbuijk, Daan Cranenbroek, Sara I Van Ameijden, Pim W Van Egmond, Margot C W Joosen, Mariska A C De Jongh, Ruth E Geuze","doi":"10.2340/17453674.2026.45364","DOIUrl":"10.2340/17453674.2026.45364","url":null,"abstract":"<p><strong>Background and purpose: </strong> Traumatic fractures of the thoracolumbar spine happen in the younger, working-age population and often compromise return to work (RTW), a key factor in functional recovery and overall quality of life. Our review summarizes the current evidence on RTW following traumatic thoracolumbar fractures without spinal cord injury.</p><p><strong>Methods: </strong> A comprehensive literature search was conducted in Embase, Medline (OvidSP), Web of Science, CINAHL and Cochrane through July 2025. Studies were included if they met the following criteria: (i) traumatic thoracolumbar spine fracture without spinal cord injury, (ii) RTW reported as an outcome measure, (iii) prospective or retrospective cohort study or case-control design, and (iv) availability of a full-text article. Risk of bias was assessed for each included study.</p><p><strong>Results: </strong> 31 studies met the inclusion criteria. Follow-up ranged from 3 to 226 months. Only 8 out of 31 studies were rated as low risk of bias. Reported RTW rates varied widely: 25% to 100% after surgical treatment (n = 19 studies) and 38% to 100% after non-surgical treatment (n = 19 studies). Pooled estimates showed that the mean RTW is between 76% and 84% in patients with a thoracolumbar spine fracture, irrespective of treatment modality.</p><p><strong>Conclusion: </strong> Estimated RTW rates range between 76% and 84%.</p>","PeriodicalId":6916,"journal":{"name":"Acta Orthopaedica","volume":"97 ","pages":"83-90"},"PeriodicalIF":2.4,"publicationDate":"2026-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12908126/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146257068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-03DOI: 10.2340/17453674.2026.45292
Chan Hee Cho, John M Abrahams, Deepti K Sharma, Lucian B Solomon, Christopher J Wall, Bart G Pijls, Stuart A Callary
Background and purpose: National joint arthroplasty registries are the gold standard for monitoring long-term acetabular implant survivorship. Sensitive radiographic surveillance (SRS) has been recommended as a complementary surveillance approach, but no study has investigated whether implants introduced with no sensitive radiographic surveillance (NSRS) are associated with higher revision rates. Therefore, we investigated whether acetabular implants with NSRS are associated with higher revision rates than those with SRS.
Methods: Acetabular implants with SRS were defined as those with published evidence of stability measurements assessed using either radiostereometric analysis or "Ein Bild Röntgen Analyse." Evidence of SRS of acetabular implant designs was sourced from 2 literature reviews. A mixed-effects model was used to pool and compare the revision rate of acetabular implants with SRS and NSRS at 5 and 10 years from 5 arthroplasty registries.
Results: There were 29 unique acetabular implant designs with SRS and 86 designs with NSRS that had matching 5- and 10-year revision rates. At 5 years, there was a mean difference of 0.8% (95% confidence interval [CI] 0.5-1.1) in mean all-cause revision rates favoring implants with SRS. Mean all-cause revision rates at 10 years for acetabular implants with SRS and NSRS were 5.2% (CI 4.9-5.5) and 7.4% (CI 7.0-7.9) respectively, with a mean difference of 1.8% (CI 1.2-2.3) favoring implants with SRS.
Conclusion: Acetabular implants with NSRS were associated with 1.8% higher pooled revision rates than those with SRS at 10 years, which represents a relative increase in acetabular revision burden of approximately 36%.
{"title":"Association of acetabular implants with sensitive radiographic surveillance on revision rates: a study based on 5 hip arthroplasty registries.","authors":"Chan Hee Cho, John M Abrahams, Deepti K Sharma, Lucian B Solomon, Christopher J Wall, Bart G Pijls, Stuart A Callary","doi":"10.2340/17453674.2026.45292","DOIUrl":"10.2340/17453674.2026.45292","url":null,"abstract":"<p><strong>Background and purpose: </strong> National joint arthroplasty registries are the gold standard for monitoring long-term acetabular implant survivorship. Sensitive radiographic surveillance (SRS) has been recommended as a complementary surveillance approach, but no study has investigated whether implants introduced with no sensitive radiographic surveillance (NSRS) are associated with higher revision rates. Therefore, we investigated whether acetabular implants with NSRS are associated with higher revision rates than those with SRS.</p><p><strong>Methods: </strong> Acetabular implants with SRS were defined as those with published evidence of stability measurements assessed using either radiostereometric analysis or \"Ein Bild Röntgen Analyse.\" Evidence of SRS of acetabular implant designs was sourced from 2 literature reviews. A mixed-effects model was used to pool and compare the revision rate of acetabular implants with SRS and NSRS at 5 and 10 years from 5 arthroplasty registries.</p><p><strong>Results: </strong> There were 29 unique acetabular implant designs with SRS and 86 designs with NSRS that had matching 5- and 10-year revision rates. At 5 years, there was a mean difference of 0.8% (95% confidence interval [CI] 0.5-1.1) in mean all-cause revision rates favoring implants with SRS. Mean all-cause revision rates at 10 years for acetabular implants with SRS and NSRS were 5.2% (CI 4.9-5.5) and 7.4% (CI 7.0-7.9) respectively, with a mean difference of 1.8% (CI 1.2-2.3) favoring implants with SRS.</p><p><strong>Conclusion: </strong> Acetabular implants with NSRS were associated with 1.8% higher pooled revision rates than those with SRS at 10 years, which represents a relative increase in acetabular revision burden of approximately 36%.</p>","PeriodicalId":6916,"journal":{"name":"Acta Orthopaedica","volume":"97 ","pages":"60-66"},"PeriodicalIF":2.4,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12869144/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146111907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-03DOI: 10.2340/17453674.2025.45182
Christian Bredgaard Jensen, Claus Varnum, Simon Kornvig, Kristine Ifigenia Bunyoz, Kirill Gromov, Anders Troelsen
Background and purpose: Tibial periprosthetic fractures (PPF), periprosthetic joint infections (PJI), and bearing dislocations (BD) are among the most common short-term complications in medial unicompartmental knee arthroplasty (mUKA). We aim to assess whether patients with these complications have patient-reported outcome measures (PROMs) that differ from patients with primary mUKA, primary total knee arthroplasty (TKA), or after revision TKA .
Methods: This observational study included 74 mUKA patients reoperated for PPF (n = 22), PJI (n = 15), or BD (n =3 7) between January 2018 and January 2023. Comparator groups included 1,940 primary mUKA, 3,485 primary TKA, and 350 reoperated TKA patients. The primary endpoint was Oxford Knee Score (OKS) at 12 months. Missing data was imputed, and multilevel Tobit regression was used to analyze differences in PROMs.
Results: At 12 months, reoperated mUKAs had lower PROM scores than primary mUKAs (OKS difference -3.3, 95% confidence interval [CI] -5.0 to -1.5) and TKAs (OKS difference -2.7, CI -4.4 to -0.9) but higher than reoperated TKAs (OKS difference: 3.0, CI 1.1 to 5.0). PPF mUKAs had 12-month scores resembling reoperated TKAs (OKS difference -0.7, CI -3.9 to 2.5). PJI mUKAs and BD mUKAs had 12-month scores resembling primary mUKAs (PJI: OKS difference -2.4, CI -6.2 to 1.5, BD: OKS difference -2.2, CI -4.7 to 0.2) and primary TKAs (PJI: OKS difference -1.7, CI -5.6 to 2.1, BD: OKS-difference -1.6, CI -4.1 to 0.8).
Conclusion: Patients reoperated for PJI and BD achieved outcomes comparable to primary mUKAs and TKAs, while PPF resulted in scores lower than primary mUKAs and TKAs, comparable to reoperated TKAs.
{"title":"Outcomes after reoperated medial unicompartmental knee arthroplasties compared with primary total and primary unicompartmental knee arthroplasties: a cohort study based on local Danish databases.","authors":"Christian Bredgaard Jensen, Claus Varnum, Simon Kornvig, Kristine Ifigenia Bunyoz, Kirill Gromov, Anders Troelsen","doi":"10.2340/17453674.2025.45182","DOIUrl":"10.2340/17453674.2025.45182","url":null,"abstract":"<p><strong>Background and purpose: </strong>Tibial periprosthetic fractures (PPF), periprosthetic joint infections (PJI), and bearing dislocations (BD) are among the most common short-term complications in medial unicompartmental knee arthroplasty (mUKA). We aim to assess whether patients with these complications have patient-reported outcome measures (PROMs) that differ from patients with primary mUKA, primary total knee arthroplasty (TKA), or after revision TKA .</p><p><strong>Methods: </strong>This observational study included 74 mUKA patients reoperated for PPF (n = 22), PJI (n = 15), or BD (n =3 7) between January 2018 and January 2023. Comparator groups included 1,940 primary mUKA, 3,485 primary TKA, and 350 reoperated TKA patients. The primary endpoint was Oxford Knee Score (OKS) at 12 months. Missing data was imputed, and multilevel Tobit regression was used to analyze differences in PROMs.</p><p><strong>Results: </strong>At 12 months, reoperated mUKAs had lower PROM scores than primary mUKAs (OKS difference -3.3, 95% confidence interval [CI] -5.0 to -1.5) and TKAs (OKS difference -2.7, CI -4.4 to -0.9) but higher than reoperated TKAs (OKS difference: 3.0, CI 1.1 to 5.0). PPF mUKAs had 12-month scores resembling reoperated TKAs (OKS difference -0.7, CI -3.9 to 2.5). PJI mUKAs and BD mUKAs had 12-month scores resembling primary mUKAs (PJI: OKS difference -2.4, CI -6.2 to 1.5, BD: OKS difference -2.2, CI -4.7 to 0.2) and primary TKAs (PJI: OKS difference -1.7, CI -5.6 to 2.1, BD: OKS-difference -1.6, CI -4.1 to 0.8).</p><p><strong>Conclusion: </strong>Patients reoperated for PJI and BD achieved outcomes comparable to primary mUKAs and TKAs, while PPF resulted in scores lower than primary mUKAs and TKAs, comparable to reoperated TKAs.</p>","PeriodicalId":6916,"journal":{"name":"Acta Orthopaedica","volume":"97 ","pages":"67-75"},"PeriodicalIF":2.4,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12869279/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146111848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-23DOI: 10.2340/17453674.2026.45363
Annette W-Dahl, Johan Kärrholm, Perna Ighani Arani, Ola Rolfson
Background and purpose: The use of a tourniquet in knee replacement surgery is debated. Given the conflicting evidence, we aimed to compare the risk of revision after total knee replacements (TKR) with or without the use of tourniquet.
Methods: In this register based observational study, we included the 5 most common cemented primary TKR models due to osteoarthritis reported to the Swedish Arthroplasty Register 2010-2024 and followed them until December 31, 2024. The first revision for implant loosening was the primary outcome. We estimated the cumulative revision rate (CRR) with 95% confidence interval (CI) using the 1-Kaplan-Meier method. We examined the use of a tourniquet regarding the risk of revision using multiple Cox regression analysis to calculate the hazard ratio (HR) with CI and adjusted for potential confounding factors.
Results: Of the 149,616 TKRs included, 65,570 (44%) were with tourniquet and 84,046 (56%) without tourniquet. The CRR was similar at all time-points for all causes and infection; however, CRR started to increase at 6-7 years for implant loosening with use of a tourniquet. In the Cox regression analysis, the use of a. tourniquet was associated with an increased risk of revision for implant loosening after 5 years (HR 1.56, CI 1.06-2.30). There was no difference in revision for all causes (HR 1.07, CI 0.99-1.15) or infection (HR 1.08, CI 0.97-1.21).
Conclusion: The use of a tourniquet was associated with an increased risk of revision for implant loosening after 5 years, while no association was found for all-cause revision or infection. Our results do not support the use of a tourniquet in TKR as a strategy to reduce the risk of revision, either due to all causes, implant loosening, or infection.
背景与目的:止血带在膝关节置换术中的应用一直存在争议。鉴于相互矛盾的证据,我们旨在比较使用止血带或不使用止血带的全膝关节置换术(TKR)后翻修的风险。方法:在这项基于登记的观察性研究中,我们纳入了2010-2024年瑞典关节成形术登记中报告的5例最常见的骨关节炎骨水泥原发性TKR模型,并随访至2024年12月31日。种植体松动的第一次翻修是主要结果。我们使用1-Kaplan-Meier方法估计累积修正率(CRR), 95%置信区间(CI)。我们使用多重Cox回归分析来计算带有CI的风险比(HR),并对潜在的混杂因素进行校正,以检查止血带的使用对翻修风险的影响。结果:纳入的149,616例tkr中,65,570例(44%)使用止血带,84,046例(56%)不使用止血带。所有病因和感染的CRR在所有时间点都相似;然而,使用止血带松动植入物的CRR在6-7岁时开始增加。在Cox回归分析中,止血带的使用与5年后假体松动的修复风险增加相关(HR 1.56, CI 1.06-2.30)。所有原因(HR 1.07, CI 0.99-1.15)或感染(HR 1.08, CI 0.97-1.21)的修订无差异。结论:止血带的使用与5年后假体松动翻修的风险增加有关,而与全因翻修或感染无关。我们的研究结果不支持在TKR中使用止血带作为降低翻修风险的策略,无论是由于各种原因,植入物松动还是感染。
{"title":"The risk of revision using tourniquet or not in primary total knee replacement: an observational study from the Swedish Knee Arthroplasty Register.","authors":"Annette W-Dahl, Johan Kärrholm, Perna Ighani Arani, Ola Rolfson","doi":"10.2340/17453674.2026.45363","DOIUrl":"10.2340/17453674.2026.45363","url":null,"abstract":"<p><strong>Background and purpose: </strong> The use of a tourniquet in knee replacement surgery is debated. Given the conflicting evidence, we aimed to compare the risk of revision after total knee replacements (TKR) with or without the use of tourniquet.</p><p><strong>Methods: </strong> In this register based observational study, we included the 5 most common cemented primary TKR models due to osteoarthritis reported to the Swedish Arthroplasty Register 2010-2024 and followed them until December 31, 2024. The first revision for implant loosening was the primary outcome. We estimated the cumulative revision rate (CRR) with 95% confidence interval (CI) using the 1-Kaplan-Meier method. We examined the use of a tourniquet regarding the risk of revision using multiple Cox regression analysis to calculate the hazard ratio (HR) with CI and adjusted for potential confounding factors.</p><p><strong>Results: </strong> Of the 149,616 TKRs included, 65,570 (44%) were with tourniquet and 84,046 (56%) without tourniquet. The CRR was similar at all time-points for all causes and infection; however, CRR started to increase at 6-7 years for implant loosening with use of a tourniquet. In the Cox regression analysis, the use of a. tourniquet was associated with an increased risk of revision for implant loosening after 5 years (HR 1.56, CI 1.06-2.30). There was no difference in revision for all causes (HR 1.07, CI 0.99-1.15) or infection (HR 1.08, CI 0.97-1.21).</p><p><strong>Conclusion: </strong> The use of a tourniquet was associated with an increased risk of revision for implant loosening after 5 years, while no association was found for all-cause revision or infection. Our results do not support the use of a tourniquet in TKR as a strategy to reduce the risk of revision, either due to all causes, implant loosening, or infection.</p>","PeriodicalId":6916,"journal":{"name":"Acta Orthopaedica","volume":"97 ","pages":"53-59"},"PeriodicalIF":2.4,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12831073/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146027872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-23DOI: 10.2340/17453674.2025.45115
Martinique Vella-Baldacchino, Alex Bottle, Justin Cobb, Alexander D Liddle
Background and purpose: Patellofemoral joint replacements (PFR) and total knee replacements (TKR) are surgical treatment options for patellofemoral joint osteoarthritis. We aimed to compare patient-reported outcome measures (PROMs) for these procedures, and revision thresholds for PFR.
Methods: Data from the National Joint Registry (2009-2021) was linked with the Hospital Episodes Statistics (HES) database. Data was then merged with the PROMs dataset and adjusted using inverse proportional treatment weighting methods. Primary PROMS were Oxford Knee Score (OKS) and EQ5D-3L at the 6-18-month mark with a minimal clinically important difference of 5 for OKS. Secondary outcome measures included threshold to revision, defined as the cut-off score at which an arthroplasty was revised. Differences in patient characteristics between those classed as best and worst outcomes were compared and regression analyses examined the influence of factors such as age, provider type (public or private healthcare), and comorbidities on PROMs with results stratified by sex.
Results: 340,449 matched records were analyzed (1,085 PFR, 339,364 TKR). The median postoperative OKS was 35 (PFR) and 38 (TKR), with a difference of -2.4. Patients with the best PFR outcomes were older (62.0 vs 57.2 years, P = 0.01). The median 6-month EQ5D-3L was 0.77 (PFR) and 0.80 (TKR). PFR had a higher revision hazard ratio (3.4, 95% confidence interval 2.7-4.4, P = 0.01), indicating a lower threshold for revision.
Conclusion: Up to 18 months, in terms of OKS and EQ5D-3L, there was no significant difference between the 2 procedures. PFR had a lower threshold for revision compared with TKR. Future research should incorporate more objective measures, such as activity level, where objective differences might be identified.
{"title":"Patient-reported outcomes following patellofemoral and total knee replacement: an analysis of the 6-18 months postoperative period from the National Joint Registry.","authors":"Martinique Vella-Baldacchino, Alex Bottle, Justin Cobb, Alexander D Liddle","doi":"10.2340/17453674.2025.45115","DOIUrl":"10.2340/17453674.2025.45115","url":null,"abstract":"<p><strong>Background and purpose: </strong> Patellofemoral joint replacements (PFR) and total knee replacements (TKR) are surgical treatment options for patellofemoral joint osteoarthritis. We aimed to compare patient-reported outcome measures (PROMs) for these procedures, and revision thresholds for PFR.</p><p><strong>Methods: </strong> Data from the National Joint Registry (2009-2021) was linked with the Hospital Episodes Statistics (HES) database. Data was then merged with the PROMs dataset and adjusted using inverse proportional treatment weighting methods. Primary PROMS were Oxford Knee Score (OKS) and EQ5D-3L at the 6-18-month mark with a minimal clinically important difference of 5 for OKS. Secondary outcome measures included threshold to revision, defined as the cut-off score at which an arthroplasty was revised. Differences in patient characteristics between those classed as best and worst outcomes were compared and regression analyses examined the influence of factors such as age, provider type (public or private healthcare), and comorbidities on PROMs with results stratified by sex.</p><p><strong>Results: </strong> 340,449 matched records were analyzed (1,085 PFR, 339,364 TKR). The median postoperative OKS was 35 (PFR) and 38 (TKR), with a difference of -2.4. Patients with the best PFR outcomes were older (62.0 vs 57.2 years, P = 0.01). The median 6-month EQ5D-3L was 0.77 (PFR) and 0.80 (TKR). PFR had a higher revision hazard ratio (3.4, 95% confidence interval 2.7-4.4, P = 0.01), indicating a lower threshold for revision.</p><p><strong>Conclusion: </strong> Up to 18 months, in terms of OKS and EQ5D-3L, there was no significant difference between the 2 procedures. PFR had a lower threshold for revision compared with TKR. Future research should incorporate more objective measures, such as activity level, where objective differences might be identified.</p>","PeriodicalId":6916,"journal":{"name":"Acta Orthopaedica","volume":"97 ","pages":"42-49"},"PeriodicalIF":2.4,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12829338/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146027877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-23DOI: 10.2340/17453674.2026.45294
Thore C Scherff, Nico Hinz, Cornelius Grimme, Karl-Heinz Frosch, Maximilian Hartel
Background and purpose: While complication rates for primary pelvic and acetabular fracture surgeries are well documented, limited data exists on complications following osteosynthesis implant removals. We aimed to evaluate the complication rates of pelvic implant removals with respect to the surgical approach, type of implant, and indication for removal.
Methods: This retrospective, consecutive case series included all patients undergoing pelvic implant removal between January 2013 and December 2023 using Kocher-Langenbeck, modified Stoppa (AIP), or ilioinguinal approaches for the removal. Isolated minimally invasive, percutaneous implant removals were excluded.
Results: 154 implant removals in 141 patients were analyzed. Overall complication rate was 34% (n = 53). Most common complications were intraoperative bleeding requiring transfusion (n = 17; 11%), postoperative anemia requiring transfusion (n = 12; 7.8%), and vascular injuries (n = 9; 5.8%). The ilioinguinal approach showed a higher complication rate (19/37; 51%) than the Kocher-Langenbeck (21/68; 31%) or the Stoppa/AIP approach (13/49; 27%). Removal of implants from the anterior pelvic ring and acetabulum (22/45; 49%) also had a higher complication risk than from the posterior pelvic ring and acetabulum (20/67; 30%) or of symphyseal plates (11/42; 26%). Removal due to infection also showed a particularly high complication rate (25/57; 44%) compared with aseptic indications, e.g., interfering material or removal for THA.
Conclusion: Pelvic implant removals, especially from the anterior pelvic ring or acetabulum, using the ilioinguinal approach, and in case of infection, are associated with a particularly high complication risk. These findings can support clinical decision-making and informing patients on the potential risks of hardware removals.
{"title":"Complication rates following open surgical removal of osteosynthesis material from the pelvis and acetabulum: a retrospective case series of 154 removals.","authors":"Thore C Scherff, Nico Hinz, Cornelius Grimme, Karl-Heinz Frosch, Maximilian Hartel","doi":"10.2340/17453674.2026.45294","DOIUrl":"10.2340/17453674.2026.45294","url":null,"abstract":"<p><strong>Background and purpose: </strong> While complication rates for primary pelvic and acetabular fracture surgeries are well documented, limited data exists on complications following osteosynthesis implant removals. We aimed to evaluate the complication rates of pelvic implant removals with respect to the surgical approach, type of implant, and indication for removal.</p><p><strong>Methods: </strong> This retrospective, consecutive case series included all patients undergoing pelvic implant removal between January 2013 and December 2023 using Kocher-Langenbeck, modified Stoppa (AIP), or ilioinguinal approaches for the removal. Isolated minimally invasive, percutaneous implant removals were excluded.</p><p><strong>Results: </strong> 154 implant removals in 141 patients were analyzed. Overall complication rate was 34% (n = 53). Most common complications were intraoperative bleeding requiring transfusion (n = 17; 11%), postoperative anemia requiring transfusion (n = 12; 7.8%), and vascular injuries (n = 9; 5.8%). The ilioinguinal approach showed a higher complication rate (19/37; 51%) than the Kocher-Langenbeck (21/68; 31%) or the Stoppa/AIP approach (13/49; 27%). Removal of implants from the anterior pelvic ring and acetabulum (22/45; 49%) also had a higher complication risk than from the posterior pelvic ring and acetabulum (20/67; 30%) or of symphyseal plates (11/42; 26%). Removal due to infection also showed a particularly high complication rate (25/57; 44%) compared with aseptic indications, e.g., interfering material or removal for THA.</p><p><strong>Conclusion: </strong> Pelvic implant removals, especially from the anterior pelvic ring or acetabulum, using the ilioinguinal approach, and in case of infection, are associated with a particularly high complication risk. These findings can support clinical decision-making and informing patients on the potential risks of hardware removals.</p>","PeriodicalId":6916,"journal":{"name":"Acta Orthopaedica","volume":"97 ","pages":"35-41"},"PeriodicalIF":2.4,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12829339/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146027794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}